Diametric Capital, LP Axonics, Inc. Transaction History

Diametric Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$66.47 - $69.65 $17,813 - $18,666	268 Added 2.03%	13,452 $904,000
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $747,137 - $914,442	13,184 New	13,184 $909,000
Q1 2023 May 11, 2023	SELL	$52.6 - $67.34 $1.19 Million - $1.52 Million	-22,598 Reduced 62.73%	13,424 $732,000
Q4 2022 Mar 29, 2023	BUY	$59.56 - $76.6 $732,051 - $941,490	12,291 Added 51.79%	36,022 $2.25 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $519,785 - $700,580	8,968 Added 60.75%	23,731 $1.67 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $583,138 - $951,032	14,763 New	14,763 $837,000

235

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.